Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Postural mobilization versus noradrenaline during off-pump coronary bypass

Official title: Comparison of Hemodynamic Management by Postural Mobilization Versus Chemical Vasoconstriction Using Noradrenaline Exclusively in Off-pump Coronary Artery Bypass Graft Surgery: A Prospective, Randomized, Comparative, Single-center Study.

Run by Infirmerie Protestante de Lyon · NCT07163858 · Data updated 2026-11-12

This will test whether using passive leg‑raising with or without noradrenaline reduces the need for noradrenaline in adults having off‑pump coronary artery bypass surgery.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment50 (estimated)
SponsorInfirmerie Protestante de Lyon
Academic / other
Locations1 site (Caluire-et-Cuire, Auvergne-Rhône-Alpes)
StatusRecruiting
StartedOctober 6, 2025
Main results expectedJuly 2027
Study endsAugust 2027
Registry record updatedNovember 4, 2026
Trial IDNCT07163858 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults undergoing isolated off‑pump coronary artery bypass grafting with left ventricular ejection fraction ≥30% who can provide informed consent are ideal candidates.

Probably not a fit

Patients with EF <30%, contraindications to passive leg raising, bilateral iliac or common femoral artery occlusion, severe renal failure (GFR <40), class III obesity (BMI >40), pregnancy, or bilateral thigh amputation are unlikely to benefit or be eligible.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

OPTICAB is a single-center randomized trial in Lyon comparing two hemodynamic management strategies during off‑pump coronary artery bypass grafting: postural mobilization (passive leg raising) with supplemental noradrenaline as needed versus noradrenaline alone. Patients are randomized intraoperatively and followed for 30 days to record vasopressor use, revascularization rates, and postoperative complications. The primary outcome is how often noradrenaline is required when passive leg raising is used as part of hemodynamic management. Secondary outcomes include perioperative hemodynamic parameters and postoperative clinical events over the 30‑day follow‑up.

Why it matters

Potential benefit: If successful, this approach could reduce reliance on vasopressors and their side effects, potentially improving recovery after off‑pump CABG.

How similar studies have gone: Passive leg raising is a well‑validated way to predict fluid responsiveness in critical care, but using it as the main intraoperative hemodynamic management strategy during off‑pump CABG is novel and not widely proven.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Adult patient
* patient requiring isolated coronary bypass surgery
* Elective procedure or medical emergency
* First cardiac surgery
* Patient with an EF ≥30%
* Mandatory affiliation to a social security system
* Signed informed consent form
* Suspension of renin-angiotensin system inhibitors and angiontensn-neprilysin receptor blockers and sartans the day before surgical procedure

Exclusion Criteria:

* Contraindication to an inotropic substance (only NA will be used)
* Contraindication to passive leg raising
* Patient in a life-threatening emergency
* History of cardiac surgery
* Bilateral iliac or common femoral artery occlusion
* EF \< 30%
* Pregnancy and breastfeeding
* Renal failure (GFR \< 40 ml/min/1.73 m²)
* Patient with bilateral thigh amputation
* Class III obesity BMI \> 40 kg/m²

Where it's running

  • Infirmerie Protestante de Lyon
    Caluire-et-Cuire, Auvergne-Rhône-Alpes, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.